• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Flexion Therapeutics, Inc. (FLXN)

    -NasdaqGM
    24.11 Down 1.18(4.67%) Aug 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:25.29
    Open:25.21
    Bid:24.10 x 100
    Ask:24.11 x 700
    1y Target Est:37.60
    Beta:N/A
    Earnings Date:Nov 11 - Nov 16 (Est.)
    Day's Range:23.89 - 25.63
    52wk Range:12.41 - 30.37
    Volume:205,499
    Avg Vol (3m):162,114
    Market Cap:518.39M
    P/E (ttm):N/A
    EPS (ttm):-1.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for FLXN

    Comparison

    Symbol% ChgMkt Cap
    FLXNDown 4.67%518.39M
    JNJDown 1.25%260.24B
    PCRXDown 2.18%2.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.30
    Quarterly EPS Est (Sep-15) :-0.64
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback